A Previously Unknown Unique Challenge for Inhibitors of SYK ATP-Binding Site: Role of SYK as A Cell Cycle Checkpoint Regulator
The identification of SYK as a molecular target in B-lineage leukemia/lymphoma cells prompted the development of SYK inhibitors as a new class of anti-cancer drug candidates. Here we report that induction of the SYK gene expression in human cells causes a significant down-regulation of evolutionaril...
Egile Nagusiak: | , , , , , |
---|---|
Formatua: | Artikulua |
Hizkuntza: | English |
Argitaratua: |
Elsevier
2014-11-01
|
Saila: | EBioMedicine |
Gaiak: | |
Sarrera elektronikoa: | http://www.sciencedirect.com/science/article/pii/S2352396414000218 |